Cryopreservation Bags and Freezing Bags Market Size, Share, Trend, Revenue Report 2026 to 2035
What is Cryopreservation Bags and Freezing Bags Market Size?
Cryopreservation Bags and Freezing Bags Market Size is valued at USD 226.87 Mn in 2025 and is predicted to reach USD 331.79 Mn by the year 2035 at a 4.0% CAGR during the forecast period for 2026 to 2035.
Cryopreservation Bags and Freezing Bags Market Size, Share & Trends Analysis Report By Type of Analyte Stored (Blood, Biologics, and Tissues), Region, And Segment Forecasts, 2026 to 2035.

Cryopreservation Bags and Freezing Bags Market Key Takeaways:
|
Cryopreservation involves preserving biological products in a closed-bag system at very low temperatures. The manufacturers of cryopreservation bags and freezing bags provide various cryobags to different companies for the long-term preservation of various biological materials such as blood samples, tissues, organs, and cells. The selection of the ideal packaging material form is an essential factor influencing cryopreservation bag manufacturing. For instance, in February 2022, OriGen Biomedical launched its cryopreservation product, CryoStore FLEX freezing bag. This EVA bag is used to store blood components and has received CE mark clearance confirming its compliance with specific requirements of the European medical device directives.
The rising preference for packaged food items is estimated to escalate the demand for freezing bags over the forecast period. Furthermore, the increasing need for storage containers that preserve the stored samples' integrity, viability, stability, and quality is a primary factor driving the growth of the cryopreservation bags and freezing bags market.
Competitive Landscape
Some of the Key Players in the Cryopreservation Bags and Freezing Bags Market:
- American Durafilm
- Biomed Device
- CellBios
- Charter Medical
- Instant Systems
- Macopharma
- OriGen Biomedical
- Sartorius
- Other Prominent Players
Market Segmentation:
The Cryopreservation Bags and Freezing Bags Market is segmented based on the type of analyte stored and region. The market is classified into blood, biologics, and tissues by the type of analyte stored.
The Blood Segment Accounted For The Highest Revenue Share Of The Cryopreservation Bags And Freezing Bags Market In 2022
In terms of the type of analyte stored, the blood segment is expected to lead the market during the projected period (2023-2031). Factors such as the technological advancements in the healthcare research sector, the increasing prevalence of blood disorders, and rising demand for advanced therapeutic medicinal products (ATMPs) and biobanking applications are predicated on creating lucrative opportunities for players involved in this market. India and China are the primary contributors to the blood segment.
Regionally, North America Holds The Highest Revenue Share
North America cryopreservation bags and freezing bags market is expected to record an enormous market share in revenue over the forecast period. The growing number of biopharmaceutical companies, technological advancements in healthcare industries, and increasing demand for cryopreservation bags and freezing bags are propelling the regional market's growth. In addition, the Asia-Pacific region is considered to increase significantly in the forthcoming years due to the growing prevalence of blood disorders and the surge in demand for ATMPs, stem cells, gene and cell therapies, and biobanking applications.

Cryopreservation Bags and Freezing Bags Market Report Scope:
| Report Attribute | Specifications |
| Market Size Value In 2025 | USD 226.87 Million |
| Revenue Forecast In 2035 | USD 331.79 Million |
| Growth Rate CAGR | CAGR of 4.0% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2024 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Type of Analyte Stored |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | American Durafilm, Biomed Device, CellBios, Charter Medical, Instant Systems, Macopharma, OriGen Biomedical, Sartorius, and Others. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Cryopreservation Bags and Freezing Bags Market-
Cryopreservation Bags and Freezing Bags Market By Type of Analyte Stored-
- Blood
- Biologics
- Tissues

Cryopreservation Bags and Freezing Bags Market By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Cryopreservation Bags and Freezing Bags Market Size is valued at USD 226.87 Mn in 2025 and is predicted to reach USD 331.79 Mn by the year 2035.
American Durafilm, Biomed Device, CellBios, Charter Medical, Instant Systems, Macopharma, OriGen Biomedical, Sartorius, and Others.
Cryopreservation Bags and Freezing Bags Market is segmented based on the type of analyte stored and region, blood, biologics, and tissues by the type of analyte stored.
North American region is leading the Cryopreservation Bags and Freezing Bags Market.
Cryopreservation Bags and Freezing Bags Market expected to grow at a 4.0% CAGR during the forecast period for 2026-2035.